Baltikameda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,600,890 | 755,704 | 1,159,261 | 184,085 | 508,049 | 429,916 | 880,383 | 364,558 |
| Profit before tax | 50,173 | 29,227 | 121,622 | -69,785 | 176,665 | 65,544 | 148,521 | 42,331 |
| Net profit | 42,281 | 24,538 | 103,724 | -69,785 | 155,200 | 55,457 | 126,056 | 33,674 |
| Equity | 107,041 | 74,605 | 138,328 | 60,206 | 215,406 | 201,569 | 300,531 | 309,205 |
| Liabilities | 473,461 | 221,035 | 157,974 | 24,298 | 168,520 | 57,686 | 177,565 | 95,123 |
| Non-current assets | 11,333 | 10,334 | 28,071 | 17,526 | 13,142 | 20,112 | 16,640 | 16,978 |
| Current assets | 567,846 | 284,452 | 266,869 | 66,356 | 370,129 | 237,590 | 460,701 | 402,680 |
| Total assets | 579,179 | 294,786 | 294,940 | 83,882 | 383,271 | 257,702 | 477,341 | 419,658 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 133,684 | 143,976 | 64,755 |
| Social insurance contributions | - | - | - | - | - | 20,157 | 27,082 | 23,273 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +70.0% | -52.8% | +53.4% | -84.1% | +176.0% | -15.4% | +104.8% | -58.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.3% | 8.3% | 35.2% | -83.2% | 40.5% | 21.5% | 26.4% | 8.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 39.5% | 32.9% | 75.0% | -115.9% | 72.0% | 27.5% | 41.9% | 10.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.6% | 3.2% | 8.9% | -37.9% | 30.5% | 12.9% | 14.3% | 9.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.1% | 3.9% | 10.5% | -37.9% | 34.8% | 15.2% | 16.9% | 11.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.4 | 3.0 | 1.1 | 0.4 | 0.8 | 0.3 | 0.6 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 640,356 | 167,934 | 252,932 | 41,679 | 101,610 | 90,509 | 155,361 | 87,493 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Baltikameda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-03-02 | 0.01 |
| 2021-12-16 | 2022-01-02 | 0.01 |
| 2021-11-16 | 2021-12-08 | 0.01 |
Baltikameda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-19 | 2024-12-21 | 0.11 |
| 2024-11-01 | 2024-12-10 | 0.11 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Baltikameda, UAB (code 304558660) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of EUR 364.6K and net profit of EUR 33.7K, with a net profit margin of 9.2%. Performance weakened compared with 2024, when revenue reached EUR 880.4K and net profit was EUR 126.1K, but it remained above 2023, when revenue was EUR 429.9K and net profit was EUR 55.5K. Over the two-year period from 2023 to 2025, revenue declined by 15.2%, reflecting the drop after the 2024 peak. Profitability also moderated, although the company stayed profitable throughout the period. At the end of 2025, total assets were EUR 419.7K, equity EUR 309.2K and liabilities EUR 95.1K, indicating a solid equity base and moderate leverage. Key ratios for 2025 show ROE of 10.9%, ROA of 8.0%, debt-to-equity of 0.31 and asset turnover of 0.87x. Revenue per employee was EUR 91.1K, while profit per employee was EUR 8.4K.